Skip to main content
. 2021 Sep 17;14(9):935. doi: 10.3390/ph14090935

Figure 3.

Figure 3

Box plots showing the distributions of the CSF metabolites altered between the studied groups: C—control group, PD—Parkinson’s disease, APDs—atypical parkinsonian disorders. Boxes extend from 25th to 75th percentiles; whiskers denote a range of measured concentrations; line and plus represent the median concentration and the mean of concentration in a group, respectively; dots, squares, and triangles show the measured concentrations in each group. * p ≤ 0.05, ** p ≤ 0.01, and *** p ≤ 0.001; ns—not significant.